Efficacy, safety, and tolerability of xanomeline for schizophrenia spectrum disorders: a systematic review
CONCLUSION: KarXT offers an innovative non-D2 blocking approach, representing a promising treatment avenue for schizophrenia.PMID:38515004 | DOI:10.1080/14656566.2024.2334424
Source: Expert Opinion on Pharmacotherapy - Category: Drugs & Pharmacology Authors: Alexia Leber Ranuk Ramachandra Felicia Ceban Angela T H Kwan Taeho Greg Rhee Jie Wu Bing Cao Muhammad Youshay Jawad Kayla M Teopiz Roger Ho Gia Han Le Diluk Ramachandra Roger S McIntyre Source Type: research
More News: Clinical Trials | Constipation | Databases & Libraries | Drugs & Pharmacology | Dyspepsia | Schizophrenia | Study